Multivariate Cox regression analysis revealed that HSPB2 mRNA overexpression is a significant predictor of poor prognosis in BrCa, independent of other clinicopathological factors, including molecular subtype and prognostic stage. This evidence concerns the gene HSPB2 and invasive breast carcinoma.